ResearcherTohoku UniversityActive in the last 2 years

Hiroyuki Suzuki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2646-5132; OpenAlex author ID A5021580294. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody-Drug Conjugate Exerted Antitumor Activity in a Pancreatic Cancer Xenograft Model Co-author DOI 10.20944/preprints202609.1232.v1 ↗
A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts. Co-author DOI 10.3390/ijms25010161 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yukinari Kato · 2 shared papers, 2023–2026 · strength 0.62
- Paper A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody-Drug Conjugate Exerted Antitumor Activity in a Pancreatic Cancer… DOI 10.20944/preprints202609.1232.v1 ↗
- Paper A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts. DOI 10.3390/ijms25010161 ↗
Mika Kato Kaneko · 2 shared papers, 2023–2026 · strength 0.62
- Paper A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody-Drug Conjugate Exerted Antitumor Activity in a Pancreatic Cancer… DOI 10.20944/preprints202609.1232.v1 ↗
- Paper A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts. DOI 10.3390/ijms25010161 ↗
Takuro Nakamura · 1 shared paper, 2026 · strength 0.39
- Paper A Cancer-Specific Anti-Podocalyxin Monoclonal Antibody-Drug Conjugate Exerted Antitumor Activity in a Pancreatic Cancer… DOI 10.20944/preprints202609.1232.v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.